CI · Cigna Group
United States · RS rating 74 · As of 2026-10-14
| Price | 289.58 USD |
|---|---|
| 1-day change | +2.5% |
| RS rating (overall / 1M / 3M / 12M) | 74 / 71 / 73 / 44 |
| Stage | Topping |
| Composite / Minervini / CANSLIM score | 29 / 30 / 22 |
| Industry group (rank) | Medical-Managed Care (13) |
| EPS growth Q/Q | -33.5% |
| Sales growth Q/Q | +3.7% |
| Distance from 52-week high | +6.3% |
| Market cap (USD) | $73.8B |